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Abstract
For patients with diabetes in acute care settings, researchers report that it is challenging for the
healthcare team to coordinate capillary blood glucose (CBG) monitoring and insulin
administration with mealtimes. If insulin dosage is calculated from CBG values that are not
updated, patients may experience dosing errors and uncontrolled CBG. Uncontrolled CBG
increases patients’ risk of complications. To improve diabetes management, some hospitals have
implemented policies aimed at improving the coordination of CBG monitoring, insulin
administration, and mealtimes. In this study, the researcher studied the effectiveness of including
an educational card on patient meal trays on the timing of CBG monitoring, insulin
administration, and meal tray delivery. The effect on glycemic control was also examined. The
educational card was placed on patient meal trays and prompted the patient to contact the nurse
to receive meal-time insulin before the consumption of the meal. Data were collected on 60
patients (control group n = 30, test group n = 30) at a 433-bed level-1 trauma center in central
Illinois. The educational card did not significantly decrease the timing between CBG monitoring,
insulin administration, and meal tray delivery, but the implications from this study can be
replicated or modified to meet the needs of other hospitals interested in improving diabetes
management.
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Improving Timing of Capillary Blood Glucose Monitoring and
Insulin Administration through Patient Education
In the acute care setting, 38-46% of patients with diabetes experience hyperglycemia
(Mendez & Umpierrez, 2014). Per the guidelines of the American Diabetes Association (ADA)
(2019), capillary blood glucose (CBG) should be maintained between 140-180 mg/dL in the
inpatient setting, and can be maintained between 110-140 mg/dL for selected, non-critical
patients. Any CBG above 180 mg/dL is considered hyperglycemia while anything below 70
mg/dL is considered hypoglycemia. Diabetes management in hospitalized patients is inadequate
and does not meet standards. Uncontrolled CBG increases the risk of complications and results
in longer hospital stays, increasing the financial burden for the patient and hospital (Majumdar et
al., 2013).
Glycemic management in the hospital setting is challenging, but can be improved through
modifiable factors. CBG monitoring, insulin administration, and meal consumption in the
inpatient setting are not done within the appropriate timeframe (Freeland, Penprase, & Anthony,
2011; Lampe, Penoyer, Hadesty, Bean, & Chamberlain, 2014; Mendez & Umpierrez, 2014).
Inadequate coordination between CBG monitoring, insulin administration, and meal
consumption results in uncontrolled CBG. According to current recommendations by the ADA
(2019), CBG monitoring should occur closely before the administration of insulin (a time
interval was not specified), and rapid-acting insulin, Novolog or Humalog, should be
administered 15 minutes before or directly after meal consumption. Few researchers identified
barriers at adhering to guidelines, but insufficient communication and coordination between the
healthcare team and low inadequate staffing are key factors (Kaisen, Parkosewich, & Bonito,
2018).
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The purpose of this study was to examine the effect of an educational card on the time
intervals between CBG monitoring, insulin administration, and meal tray delivery. Time of meal
tray delivery served as a proxy for timing of meal consumption, as the hospital requested the
researcher have no direct patient contact. The aim of the study was to address the following
questions:
1. Does the placement of an educational card on patient meal trays shorten the time
intervals between:
a. CBG and meal tray delivery,
b. the administration of insulin and meal tray delivery,
c. and CBG and the administration of insulin?
2. Is the incidence of hypoglycemia, defined as any CBG <70mg/dL, decreased in the
interval after meal tray delivery and before the next meal after the implementation of
the educational card?
3. Is the percentage of patients in blood glucose range, measured by a target range of 70180 mg/dL, increased after the implementation of the educational card?
Literature Review
Research published from 2010 to 2019 is limited on interventions to improve glycemic
management in the inpatient setting, but some researchers were successful at lowering the
incidence of uncontrolled CBG and improving the timing between CBG monitoring, insulin
administration, and meal consumption (Engle, Ferguson, & Fields, 2016; Yamamoto,
Malatestinic, Lehman, & Juneja, 2010). For example, instead of dietary staff, nurses delivered
meal trays to patients receiving insulin, which improved CBG management and timing. This

CBG MONITORING AND INSULIN ADMINISTRATION

5

additional responsibility strained the nursing staff, interrupted work flow, and was not feasible
during times of high census (Engle et al., 2016).
Other researchers developed markings and identification for patient meal trays, which
improved the coordination of CBG monitoring and insulin administration. These interventions
are low-cost, but require the coordination between nursing and dietary staff (Yamamoto et al.,
2010). Coordination of CBG monitoring and insulin administration improved with increased
communication between nursing and dietary staff. Nurses could plan insulin administration
accordingly as they were informed of meal tray delivery (Engle et al., 2016; Yamamoto et al.,
2010). Improved communication with certified nursing assistants (CNAs) also facilitated CBG
monitoring closer to insulin administration (Kaisen et al., 2018).
According to researchers and the ADA, inpatient diabetes education is essential at
improving diabetes management (Powers et al., 2015). Inpatient glycemic management improves
when patients are able to identify the need to have insulin before meal consumption. Inpatient
diabetes education also promotes replication and adherence to teaching upon discharge. Patient
education increases autonomy, promotes healthy habits, and provides a greater sense of health
awareness (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018).
Research is limited on the effectiveness of interventions to promote glycemic
management in the inpatient setting. Inpatient glycemic management can improve through the
coordination of CBG monitoring, insulin administration, and meal consumption. Few researchers
have identified solutions at improving timing; therefore, further research is needed. It is possible
that facilities have made practice changes to improve the coordination of CBG and insulin
administration, but have not published, evaluated, or disseminated that change. Appendix A
provides greater detail on the current published research within this literature review.
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Methods
Study Design
A quasi-experimental, non-equivalent control group before-after design with
retrospective chart reviews was used in the study. Data was collected from the control group
without the educational card, and then data was collected from the test group with the
educational card. The control and test groups consisted of different participants and data
collection occurred on separate days.
Participants and Sampling Procedures
The total sample size was 60 with 30 participants in the control group and 30 participants
in the test group. Inclusion criteria included English-speaking patients prescribed rapid-acting
meal-time insulin admitted to non-critical, acute care units. Over the period of two months, the
researcher worked with an advanced practice register nurse (APRN) with a specialty in diabetes
to select participants for the study. Each day, the APRN examined unit census and created a list
of patients on rapid-acting meal-time insulin in non-critical, acute care units. Exclusion criteria
included patients not prescribed rapid-acting meal-time insulin, not assigned to non-critical,
acute care units, or non-English speaking.
The study was conducted at 433-bed level-1 trauma center in central Illinois. Institutional
Review Board (IRB) approval was granted from Illinois Wesleyan University. The hospital IRB
approved the study as a quality improvement (QI) project with no direct participant contact.
Participant consent was not obtained as there was no direct participant contact and minimal risk
to participants. The educational card was created on the basis of accepted and published
guidelines on diabetes care. The waiver of consent did not adversely affect the rights and welfare
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of the subjects and all data collected were de-identified and stored in a password protected and
encrypted computer to minimize risk of exposure of health information.
Patient Education Card
The patient education card (Appendix B) was created by the researcher in collaboration
with the APRN diabetes specialist. The goal of the education card was to catch the attention of
the participant and prompt the participant to call the nurse to receive insulin before proceeding to
meal consumption. Nurses, CNAs, dietary staff, and unit managers were notified of the
intervention via email. The card used plain and simple language. The researcher used Microsoft
Office PowerPoint® and images in the Creative Commons labeled for reuse to create the card.
Data Collection
Data collection occurred in collaboration with the APRN and dietary staff. At the
beginning of the day, the APRN informed dietary staff of the room numbers associated with
study participants. Dietary staff informed the APRN when the participant ordered and when the
meal tray left the kitchen. The researcher or the APRN went to the unit and recorded the time of
meal tray delivery to the nurse’s station and subsequently to the patient room. Paired data were
not available for every patient because of physical availability limitations of the researcher and
APRN. For example, meal trays were often delivered at the same time which made it impossible
to record the time the tray reached the nurse’s station for multiple units. Data collection occurred
first with the control group and then proceeded with the test group. For the test group, the
researcher or APRN placed the educational card directly on patient meal trays prior to delivery
into the patient room.
The researcher and APRN used retrospective chart reviews to collect demographic
information, clinical characteristics, CBG values, and the timing of CBG monitoring and insulin
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administration. CBG values before and after the observed meal were recorded. Paired data were
not available for every participant due to discharges and procedures; therefore, some results from
the control and test groups have sample size less than 30. Insulin timing was only recorded if
insulin was administered. Some patients refused insulin or insulin was not given due to clinical
indications not met (e.g., hypoglycemia). Participant unit, age, gender, hemoglobin A1C,
diabetes type, primary diagnosis, length of stay (LOS), meal observed and diet order were
recorded. Data collection occurred from November 2019 through January 2020.
Data Analysis
Data were analyzed using IBM SPSS Statistics version 26. Descriptive statistics were
used to analyze and report data using percentages, means, and standard deviations. Demographic
data from the control and test groups were compared through descriptive analysis, chi-squared
tests, and independent samples t-tests. Mean time intervals and CBG values from the control and
test groups were compared through chi-squared tests and independent samples t-tests. Percent of
the control and test groups in range was compared using chi-squared tests. Subgroups were
created within the data from hemoglobin A1C, diet ordered, and meal observed and analyzed
using independent samples t-tests.
Results
Demographic Characteristics
The demographic characteristics of the control and test groups did not differ significantly
(Appendix C), indicating both groups had similar participants. The average age in the control
group was 67.03 (SD = 13.86) and 65.07 (SD = 12.08) in the test group (t(58) = 0.59, p = 0.56).
Gender did not differ significantly between groups (X2(32, N = 60) = 31.82, p = 0.48). In the
control group, 43% of participants were male and 57% of participants were female. In the test
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group, 37% of participants were male and 63% of participants were female. Average hemoglobin
A1C in the control group was 7.93 (SD = 1.49) and 8.03 (SD = 1.95) in the test group (t(56) =
-0.23, p = 0.82).
Almost all participants had type 2 diabetes, only two participants had type 1 diabetes in
the test group. Primary diagnoses were placed into nine categories: musculoskeletal, infection,
gastrointestinal, cardiac, renal, neurologic, endocrine, pulmonary, and psychiatric. The primary
diagnoses of the control and test groups did not differ significantly (X2(8, N = 60) = 9.05, p =
0.34). The most common diagnoses between groups were infection and cardiac related. About
37% of participants had infection as the primary diagnosis in the control and about 27% in the
test group. Both groups had 20% of participants with a cardiac-related diagnosis.
The average LOS was 6.17 days (SD = 5.22) in the control group and 6.21 days (SD =
4.20) in the test group (t(57) = -0.03, p = 0.97). There was not a significant difference in diet
between groups (X2(1, N = 60) = 3.27, p = 0.07). The majority of participants in both groups
were on diabetic diets, 77% in the control group and 93% in the test group. The majority of
observed meals were from lunch, 77% in the control groups and 67% in the test group.
Participants were located in nine different non-critical, acute care units. The majority of
participants were located on three different units: a cardiopulmonary unit (30%), a medical
surgical unit (22%), and an orthopedic unit (17%). A complete participant distribution between
units is found in Appendix D.
Time Intervals
The first aim of the study was to examine if the educational card shortened the time
intervals between:
a. CBG and meal tray delivery,
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b. the administration of insulin and meal tray delivery,
c. and CBG and the administration of insulin.
The first aim of the study was not met. There was actually an increase in the time intervals (in
minutes) between:
a. CBG and meal tray delivery before (M = 35, SD= 46) and after (M = 47, SD =
68) implementation (t(56) = -0.83, p= 0.15),
b. insulin administration and meal tray delivery before (M = 27, SD = 21) and after
(M = 32, SD = 45) implementation (t(45) = -.47, p = 0.07),
c. and CBG and insulin administration before (M = 45, SD = 44) and after (M = 65,
SD = 77) implementation (t(44) = -1.09, p = 0.03).
Of the three measured intervals, the interval between CBG and insulin administration achieved
statistical significance, but the time interval increased. Graphic representation of results is found
in Appendix E.
The time interval between meal tray delivery to the nurse’s station and to the patient
room was also analyzed. The educational card did not significantly decrease the mean time
interval (in minutes) between tray delivery to the nursing station and tray delivery to the patient
room before (M = 34, SD = 72) and after (M = 11, SD = 12) implementation (t(29) = 1.24, p =
0.22).
Incidence of Hypoglycemia
The second aim of the study was to examine if the incidence of hypoglycemia (CBG of
less than 70 mg/dL) decreased in the interval after meal tray delivery and before the next meal.
There were insufficient data to run meaningful statistics to test this aim. The control group had
one incidence and the test group had three incidences of hypoglycemia.
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Percent in Blood Glucose Range
The third aim of the study was to examine if the percentage of patients in range,
measured by a target CBG range of 70-180 mg/dL increased after the implementation of the
educational card. In range was calculated using ADA (2019) standards of hypo- and
hyperglycemia in the inpatient setting. Anything below 70 mg/dL is hypoglycemia and anything
above 180 mg/dL is hyperglycemia, with any measure between 70-180mg/dL considered in
range. The post-meal CBG was used to determine in range or out of range. There was not a
significant increase in patients in range after the implementation of the educational card, (X2(1, N
= 53) = 1.52, p = 0.22). About 58% of participants were in range in the control group and about
41% in the test group were in range.
Glycemic Control
Data were collected for glycemic control through chart review, noting the CBG recorded
before the observed meal (pre-meal CBG) and the next CBG recorded after the observed meal
(post-meal CBG). The aim was to gauge glycemic control in the non-critical, acute care setting
and if the educational card effected post-meal glycemic control. There was not a significant
difference between pre-meal CBG in the control (M = 168, SD = 72) and test (M = 174, SD =
81) groups (t(57) = -0.28, p = 0.78). There was also not a significant difference between postmeal CBG in the control (M = 172, SD = 75) and test (M = 177, SD = 91) groups (t(51) = -0.24,
p = 0.81). The educational card did not impact post-meal glycemic control in this sample.
Subgroups
Hemoglobin A1C. Hemoglobin A1C was broken into four groups: 1) control group
participants with A1C < 7; 2) test group participants with an AlC < 7; 3) control group
participants with A1C >7; and 4) test group participants with an A1C > 7. A1C categories were
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based on ADA (2019) recommended A1C target of 7 or less. Hemoglobin A1C tests average
CBG control over a 3-month period. An A1C of < 7 indicates an average CBG < 154 mg/dL and
an A1C > 7 indicates an average CBG > 154 mg/dL. The goal was to determine if glycemic
control varied in response to the educational card when compared to well-controlled CBG and
poorly controlled CBG. Groups 1 and 2 were compared with post-meal CBG using independent
samples t-tests. The same analysis was conducted for groups 3 and 4. Post-meal CBG did not
differ significantly between the control group (M = 151.14, SD = 55.87) and the test group (M =
147.50, SD = 77.65) with an A1C of < 7 (t(11) = .10, p = 0.92). Similarly, post-meal CBG did
not differ significantly between the control group (M = 179.61, SD = 83.27) and test group (M =
190.70, SD = 93.61) with an A1C of > 7 (t(36) = -.38, p = 0.70).
Diet order. Diet ordered was broken into four groups: 1) control group participants on a
diabetic diet; 2) test group participants on a diabetic diet; 3) control group participants on a nondiabetic diet; and 4) test group participants on a non-diabetic diet. The goal was to determine if
glycemic control varied in response to the educational card when comparing diets. Groups 1 and
2 were compared with post-meal CBG using independent samples t-tests. The same analysis was
conducted for groups 3 and 4. Post-meal CBG did not differ significantly between the control
group (M = 181.89, SD = 83.24) and test group (M = 180.64, SD = 92.48) on a diabetic diet
(t(42) = .05, p = 0.96). Similarly, post-meal CBG did not differ significantly between the control
group (M = 144.14, SD = 35.08) and test group (M = 135.00, SD = 67.88) on a non-diabetic diet
(t(7) = .28, p = 0.79).
Meal observed. Meal observed were placed into four groups: 1) breakfast observed for
control group; 2) breakfast observed for test group; 3) lunch observed for control group; and 4)
lunch observed for test group. The goal was to determine if glycemic control and the time
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intervals varied in response to the educational card when compared to the observed meal. Groups
1 and 2 were compared with post-meal CBG and time intervals using independent samples ttests. The same analysis was conducted for groups 3 and 4. Post-meal CBG did not differ
significantly between the control group (M = 199.4, SD = 92.85) and test group (M = 128.00, SD
= 61.43) during breakfast (t(7) = 1.32, p = 0.23). Similarly, post-meal CBG did not differ
significantly between the control group (M = 165.14, SD = 70.77) and test group (M = 185.83,
SD = 93.18) during lunch (t(42) = -0.82, p = 0.42).
There was not a significant difference in the interval of time (in minutes) during breakfast
between:
a. CBG and meal tray delivery between the control (M = 98, SD = 68) and test (M=
55, SD = 42) groups (t(8) = 1.19, p = 0.27).
b. the administration of insulin and meal tray delivery between the control (M = 26,
SD = 21) and test (M = 19, SD = 15) groups (t(6) = 0.53, p = 0.62,
c. and CBG and the administration of insulin between the control (M = 102*, SD =
56) and test (M = 73, SD = 65) groups, (t(5) = 0.63, p = 0.56). *Mean CBG was
calculated manually due to one outlier within the data.
Similarly, there was not a significant difference in the interval of time (in minutes) during
lunch between:
a. CBG and meal tray delivery between the control (M = 22, SD = 26) and test (M=
46, SD = 74) groups (t(46) = -1.51, p = 0.14).
b. the administration of insulin and meal tray delivery between the control (M = 27,
SD = 23) and test (M = 34, SD = 49) groups (t(37) = -0.58, p = 0.57,
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c. and CBG and the administration of insulin between the control (M = 32, SD = 30)
and test (M = 64, SD = 80) groups, (t(37) = -1.61, p = 0.12).
Discussion
This study examined the effectiveness of an educational card on reducing the time
intervals between CBG and meal tray delivery, the administration of insulin and meal tray
delivery, and CBG and the administration of insulin. Impact on glycemic control was also
analyzed. When comparing the control to the test group, the educational card was ineffective at
reducing the time intervals and did not have a significant impact on glycemic control. The time
intervals in this sample actually increased with the implementation of the educational card which
was unexpected and inconsistent with similar studies.
Time Intervals
According to current recommendations by ADA (2019), CBG monitoring should occur
closely before the administration of insulin (a time interval was not specified), and rapid-acting
insulin, Novolog or Humalog, should be administered 15 minutes before or directly after meal
consumption. In this study, CBG monitoring did not occur according to current guidelines. On
average, CBG monitoring occurred 45 minutes before or after insulin administration in the
control group and 77 minutes before or after insulin administration in the test group. This is
alarming because if insulin dosage is based on CBG values that are not current, it could lead to
dosing errors and uncontrolled CBG.
Similarly, rapid-acting insulin administration did not occur within current guidelines. On
average insulin administration occurred 27 minutes before or after meal tray delivery in the
control group and 32 minutes before or after meal tray delivery in the test group. Insulin that is
not administered on-time severely increases patients’ risk for hyperglycemia. Patient safety is at
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risk because of the lack of coordination of CBG monitoring, insulin administration, and meal
tray delivery.
The educational card did not decrease the time intervals. All time intervals increased in
the test group compared to the control group, but the only interval that increased significantly
was the time interval between CBG and insulin administration. Although it is unclear why the
increase in time between CBG and insulin administration for the test group was statistically
significant, study limitations likely contributed (see Limitations section). The educational card
was created based on current recommendations from ADA (2019) and the APRN diabetes
specialist. Yamamoto et al. (2010) had success improving the coordination of CBG monitoring
and insulin administration through meal tray markings and identification so it is unlikely the
educational card was the cause of the increase in the time intervals. More research is needed on
the intervention or different ways to improve the coordination of CBG and insulin
administration.
The educational card did improve the timing between tray delivery to the nursing station
and to the patient room by 23 minutes in the test group. This finding was not significant and
could be attributed to the Hawthorne effect. Because the nurses and CNAs knew they were being
observed by the researcher and APRN, it could have prompted them to deliver the meal tray into
the patient room quicker.
Percent in Blood Glucose Range
The educational card did not significantly impact the percent of participants in range
(CBG 70-180 mg/dL), although the percentage of participants in range actually decreased by
17% with the implementation of the educational card in the test group. Again, this can be
attributed to study limitations (see Limitations section) and confounding factors that impact

CBG MONITORING AND INSULIN ADMINISTRATION

16

glycemic control. For example, glycemic control is impacted by patient acuity, stress, insulin
dosage, and other factors; none of these variables were included in the analysis.
About 41-58% of total study participants were in range during the study. Since there were
so few incidences of hypoglycemia, most of those participants experienced hyperglycemia, or a
CBG of > 180 md/dL. This is consistent with other studies that examine glycemic control in the
acute care setting; about 38-46% of patients with diabetes experience hyperglycemia (Mendez &
Umpierrez, 2014). There is a need to re-examine diabetes management in the inpatient setting
and research interventions to improve glycemic control.
Glycemic Control
The mean pre-meal and post-meal CBGs of both groups fell within the recommended
non-critical, acute care setting recommendations of 140 – 180 mg/dL. However, standard
deviations of 72 mg/dL, 81 mg/dL, 75 mg/dL, and 91 md/dL indicate large variations among
patients and inadequate glycemic control. The educational card did not significantly impact
glycemic control or the large fluctuations of CBGs between groups.
Although the educational card was ineffective at improving glycemic control, this study
highlights concerning results. In this sample, glycemic control was inadequate which has several
negative implications. Patient health and safety is at risk. Patient’s with uncontrolled CBG
during hospitalization are at greater risk for poor clinical outcomes such as infection and death
(Baker et al., 2006). Uncontrolled CBG also results in longer hospital stays which costs the
patient and hospitals money. One hospital saved more than $3000 per patient with improved
glycemic control (Cardona et al., 2017). healthcare staff have a responsibility to model proper
diabetes management in order to promote optimal diabetes management upon discharge.
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Subgroups
Hemoglobin A1C. The educational card did not impact glycemic control in participants
with an A1C < 7 and > 7. An A1C of < 7 indicates an average CBG < 154 mg/dL and an A1C >
7 indicates an average CBG > 154 mg/dL (ADA, 2019). This is consistent with findings as
participants with an A1C < 7 had mean CBGs of 147 – 151 mg/dL and participants with an A1C
> 7 had mean CBGs of 180 – 191 mg/dL.
Participants with an A1C < 7 have optimal glycemic management which indicates proper
diabetes management in the outpatient setting. Often, patients are not allowed to manage their
diabetes in the hospital, despite having optimal control in the outpatient setting. These patients
could benefit from more autonomy and self-diabetes management within the hospitalized setting.
This reduces the workload of the healthcare staff, results in better glycemic management, and
improves meal-time insulin coordination (Mabrey & Setji, 2015). Diabetes self-management
increases autonomy and satisfaction. For patients without optimal diabetes management, or with
an A1C >7, patient education is essential at promoting healthy habits, increasing health
awareness, and autonomy (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018).
Diet Ordered. Similarly, the educational card did not impact glycemic control in
participants on a diabetic or non-diabetic diet. Surprisingly, participants on a non-diabetic diet
had better CBG control then those on a diabetic diet. CBG ranged from 135 – 144 mg/dL in the
non-diabetic diet participants and 181 – 182 mg/dL in the diabetic group participants. This is
unexpected because the purpose of a diabetic diet is to prevent spikes in CBG and improve
glycemic control through limiting refined sugar intake, foods high in salt, and fried foods
(National Institute of Diabetes and Digestive and Kidney Diseases, 2016). Of course, the
fluctuations in CBG could be caused by other factors outside the researcher’s control. For
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example, without direct observation the exact contents of the meal were not examined and it was
unknown if the participant had a snack before the post-meal CBG was checked. More research is
warranted on the effect of diet in the non-critical, acute care setting.
Meal Observed. When considered separately, the educational card did not significantly
impact glycemic control during breakfast or lunch. The mean CBG decreased by 71 mg/dL from
the control to the test groups during breakfast, but the number of participants in that group were
small so the findings were insignificant. A larger sample size may produce significant results.
The mean CBG was consistent between breakfast and lunch.
The educational card did not significantly impact the time intervals during breakfast or
lunch. All time intervals decreased in the test group during breakfast, but still did not meet
standards and was insignificant due to small group sample sizes. A larger sample size may
produce significant results. Overall, timing was slightly better for the control and test groups
during lunch, which can be attributed to issues at breakfast such as shift change and increased
patient needs (e.g., medication orders). Few studies compare diabetes management between
meals in hospitals patients. Future research is needed on the impact of meal time on glycemic
control. Breakfast and dinner are busy times for the healthcare staff due to patient needs and
administration responsibilities (e.g., charting, shift change). Future studies should examine nurse
workload throughout the day and the impact on diabetes management.
Limitations
When comparing the control and test groups, the educational card was ineffective at
improving the time intervals and glycemic control in this sample. Insignificant results are
attributed to study design and confounding variables outside the researcher’s control. The
researcher utilized a quasi-experimental, non-equivalent control group before-after design in this
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study. The non-equivalent control group design may have introduced differences in staffing, unit
census, and patient acuity. This can impact nursing care and thus, diabetes management. This
study was strictly observational and did not have an experimental design. Meal tray delivery into
the patient room was used as a substitute for meal consumption, so the researcher could not
record when the patient actually consumed the meal. It is possible that the patient could have
started eating long after meal tray delivery. The nutritional content, such as carbohydrate or
sugar content, of meals was not accounted for nor were snacks between meals. It was also
unknown whether or not the patient noticed the educational card on the tray and called the nurse.
Demographic characteristics were similar between groups, but factors that impact
workflow were not accounted for, such as hospital or unit census, and staffing patterns. The lack
of intervention randomization may result in unaccounted differences between groups. Sample
sizes were also small due to research and APRN time constraints. It is possible that significant
results would occur with larger sample sizes.
It is also unknown if the educational card effectively prompted the patient to call the
nurse and receive insulin before eating. The patient did not receive formal education on the
educational card so it is unknown if the patient understood the educational card or the
importance of waiting to eat until insulin is received. The educational card stated, “call your
nurse for your insulin shot BEFORE you start eating,” which could have prompted the patient to
call the nurse first and then start eating; instead of calling the nurse, receiving insulin, and then
eating. Rewording of the educational card may be necessary and could include language such as,
“call your nurse and wait for your insulin shot BEFORE you start eating.” It is important to
educate patients on the intervention to promote compliance upon discharge and improve
glycemic control (Cobaugh et al., 2013; Engle et al., 2016; Kaisen et al., 2018).
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The healthcare staff, which include nurses and CNAs, had mixed compliance to the
educational card. Some employees verbalized approval of the intervention while others
expressed feelings of annoyance and displeasure. Some nurses and CNAs removed the
educational card before the tray was delivered. Since those patients did not see the card, they
were removed from the study. It is also possible that the healthcare staff removed the card while
in the patient room. This reduces intervention fidelity and impacts the data from the test group,
which makes insignificant results more likely. The healthcare staff was notified of the
intervention via email and many employees reported that they were not aware of the intervention
which created confusion on the purpose of the card. Per hospital request, the healthcare staff did
not receive formal education or module instructions on the use or importance of the educational
card. Formal and trackable education could have enhanced compliance.
Proper diabetes management is important to reduce complications. Diabetes is associated
with long-term complications such as retinopathy, kidney disease, heart disease, strokes, and
neuropathy (Corsino, Dhatariya, & Umpierrez, 2017). Uncontrolled diabetes also increases risk
of mortality and decreases life expectancy up to 15 years (Mannucci, Dicembrini, Lauria, &
Pozzilli, 2013). Improved glycemic management can reduce the risk of complications and
mortality by 16 – 57% (Holman, Paul, Bethel, Matthews, & Neil, 2008; Mannucci et al., 2013;
Nathan et al., 2005).
There are many studies that examine glycemic management in the hospital setting, but
few that address the specific time intervals between CBG monitoring, meal consumption, and
insulin administration. Research is limited on interventions to improve diabetes management in
the hospital setting. Each healthcare system is unique and faces different problems. It is
important for healthcare systems to examine diabetes management in their own facilities and
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tailor interventions to best meet the needs of the healthcare staff and patients. To the researcher’s
knowledge, this study is the first to examine the effectiveness of a patient educational card on
timing and glycemic control.
The implications of this study inform hospitals of the need to create better education or
policies to improve glycemic management. Diabetes management is inadequate in the hospital
setting and interventions must be developed to address the problem. Even though the education
was ineffective, it can be modified to fit each hospital’s needs. It is also important to promote
communication between nurses, CNAs, dietary staff, and the patient to promote optimal diabetes
management and glycemic control.
Future Research
The educational card may still be a useful tool within hospitals, but further research is
needed and should include: standardized and trackable staff and patient education,
interdisciplinary coordination between nurses, CNAs, and dietary staff, larger sample sizes, true
experimental design, and direct patient contact. The placement of the educational card was the
sole responsibility of the researcher and APRN, and was not feasible for all patients if meals
were ordered at the same time and on different units. Healthcare facilities face unique challenges
on who will place the educational card. Some facilities were successful at dietary staff placing
markings on patient meal trays that alerted the healthcare staff of patients on insulin, but that
increases the workload of dietary staff and may disclose confidential patient information
(Yamamoto et al., 2010).
It would be useful if the patient was educated on the importance of receiving insulin
before eating at some point during hospitalization, ideally during admission. An educational card
can then be placed in patient rooms to serve as a daily reminder of the education. This removes
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the barrier of placement of the educational card and makes the card more noticeable as opposed
to on patient meal trays which can be easily missed and removed.
While CBG measurement and automated documentation in electronic medical records are
reliable and valid tools, there were limitations with the measurement of time intervals within this
study. Interrater reliability must be addressed in future studies to address if data collection
occurred consistently between data collectors. Furthermore, meal tray delivery is not a valid way
to measure meal consumption. Direct patient contact to observe the exact timing and duration of
meal consumption, the contents of the meal, and if insulin was administered before or after meal
consumption would enhance both reliability and validity of data collection. There is also a need
to identify if patients saw the educational card, if they understood it, and if they called the nurse
before meal consumption; understanding intervention fidelity in the test group would improve
interpretation of statistical conclusion validity.
Time-in-range (TIR) can also be analyzed in the future. TIR is the percentage a patient
spends in-range, with a CBG of 70 – 180 mg/dL. At the beginning of hospitalization for noncritical patients on rapid-acting insulin, patients can be randomly assigned to control or test
groups. The test groups have the educational card for their entire hospitalization and CBG is
examined for their entire stay. TIR is then compared between the control and test groups. This
way allows the patient to receive formal education on the educational card and allows them to
see it more than once, which may increase retention and compliance.
TIR is important to consider when implementing any intervention aimed at improving
glycemic management because it provides a more wholistic view than mean glucose. Mean
glucose only collects data from one point in a patient’s hospitalization, which makes it difficult
to analyze improvements or fluctuations in blood glucose. Improvements in mean glucose could
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also be attributed to outliers, such as extreme incidences of hypoglycemia. Ideally, TIR would be
measured with use of continuous CBG monitoring, which is currently not used routinely in
inpatient settings.
Conclusion
Following implementation of an educational card, there was no reduction in the time
intervals between CBG monitoring, insulin administration, and meal tray delivery. Timing still
does not meet current standards which impacts glycemic control. More research is needed to
address the needs of hospitalized patients with diabetes. The study had a small sample size and
cannot be generalized to all patients due to confounding influences and the many other factors
(e.g., patient acuity, unit census) that impact glycemic control and diabetes management.
Hospitals can use the results of this study to utilize the educational card in a different manner or
tailor other interventions to meet the needs of patients with diabetes.
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Appendix A
Table 1: Literature Review Studies
Author
Yamamoto et al.,
2010

Study
Experimental

Aim
Improve timing
of inpatient
insulin
administration
related to meal
delivery and
procedure
scheduling

Findings
The timing of
inpatient
insulin
administration
related to meal
delivery and
testing
improved

Limitations
Additional
protocol may
have contributed
to improved
glycemic control,
paired data not
available for
every patient

Engle et al.,
2016

Quality
Improvement

Modify the meal
delivery process
to improve the
timing between
blood glucose
monitoring and
insulin
administration
and improve
glycemic control

Blood glucose
control and the
timing between
blood glucose
monitoring and
insulin
administration
improved after
the change

Additional
protocol may
have contributed
to improved
glycemic control

Kaisen et al.,
2018

Descriptivecorrelational
study

Identify factors
that lead to
timely blood
glucose
monitoring and
insulin
administration

Communication
with CNAs,
fewer patients,
and patients
waiting for
insulin prior to
eating were key
factors and
receiving
insulin on time

Response bias,
social
desirability,
Hawthorne
effect, limited
generalizability

Cobaugh et al.,
2013

Expert
consensus panel

Provide
recommendations
for safe insulin
administration

Development
of insulin
protocol,
hospitals must
coordinate
insulin delivery
better, and
standardize
education

Limited
knowledge of
application
within practice
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Appendix B
Patient Education Card

Call your nurse for your insulin shot BEFORE you start eating
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Appendix C
Table 2: Demographic Characteristics
Characteristic
Mean age

Control Group
67 ± 14
N= 30

Test Group
65 ± 12
N= 30

p-value
p = 0.56

Male: 43%
Female: 57%
N= 30

Male: 37%
Female: 63%
N= 30

p = 0.48

7.93 ± 1.49
N= 29

8.03 ± 1.95
N= 29

p = 0.82

Type 2: 100%
Type 1: 0%
N= 30

Type 2: 93%
Type 1: 7%
N= 30

--

Primary Diagnosis

Musculoskeletal: 5
Infection: 11
GI: 6
Cardiac: 1
Renal: 1
Neuro: 1
Endocrine: 1
Pulmonary: 1
Psych: 0
N= 30

Musculoskeletal: 4
Infection: 8
GI: 1
Cardiac: 6
Renal: 0
Neuro: 1
Endocrine: 3
Pulmonary: 5
Psych: 2
N= 30

p = 0.34

Mean Length of Stay

6±5
N= 30
Diabetic: 77%
Nondiabetic: 23%
N= 30

6±4
N= 29
Diabetic: 93%
Nondiabetic: 7%
N= 30

p = 0.97

Breakfast: 23%
Breakfast: 37%
Lunch: 77%
Lunch: 67%
N= 30
N= 30
No statistically significant differences between groups (all p-values>
0.05).

p = 1.0

Gender

Mean Hemoglobin A1C
Diabetes Type

Diet Order

Meal Observed

p = 0.07
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Appendix D
Table 3: Participant Unit Distribution
Unit

Unit Type

Control Group
N= 30

Test Group
N= 30

Unit 1

Orthopedic

17%

17%

Unit 2

Medical Surgical

17%

7%

Unit 3

Medical Surgical

27%

17%

Unit 4

13%

3%

Unit 5

Cardiac Medical
Surgical
Cardiopulmonary

27%

33%

Unit 6

Surgical Trauma

0%

3%

Unit 7

Advanced Care

0%

10%

Unit 8

Medical Surgical

0%

7%

Unit 9

Medical Surgical

0%

3%

No statistically significant differences between groups, p > 0.05.
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Appendix E
Table 4: Time Intervals between Control and Test Groups

Time Intervals

Mean Time Interval (minutes)

160
140
120
100
80

Control Group

60

65
47

40

45

35
27

20
0

N=29 N=29

Test Group

32

N=22 N=25

CBG and meal Insulin and meal
tray delivery
tray delivery

N=22 N=24

CBG and
insulin*

*p = 0.03
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Appendix F
Table 5: Time Intervals (in minutes)
Group Statistics
IV

N

Mean

Std. Deviation

Std. Error Mean

Time between CBG and Tray

Control Group

29

35:18

46:03

08:33

Delivery

Test Group

29

48:08

69:35

12:55

Time between Insulin

Control Group

22

27:08

21:50

04:39

Administration and Tray

Test Group

25

32:12

45:50

09:10

Time between Insulin

Control Group

22

45:00

44:55

09:34

Administration and CBG

Test Group

24

65:40

77:37

15:50

Time between Tray to Nurse’s

Control Group

15

34:28

72:04

18:36

Delivery

Station and Tray to Room
Test Group
16
11:45
12:06
03:01
Note. Paired data were not always available in the control and test groups due to patient discharges, procedures, and lack of
insulin administration, resulting in variability in N.

Levene's Test for Equality of
Variances
F
Time between CBG and Tray Delivery

Equal variances assumed

Sig.
2.156

t
.148

Equal variances not

df

Sig. (2-tailed)

-.828

56

.411

-.828

48.583

.412

-.473

45

.639

-.492

35.291

.625

-1.092

44

.281

-1.116

37.405

.271

1.244

29

.224

1.205

14.742

.247

assumed
Time between Insulin Administration and

Equal variances assumed

3.368

.073

Tray Delivery
Equal variances not
assumed
Time between Insulin Administration and
CBG

Equal variances assumed

4.790

.034

Equal variances not
assumed

Time between Tray to Nurse’s Station and Equal variances assumed

4.551

.041

Tray to Room
Equal variances not
assumed
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Table 6: Percent in Blood Glucose Range
IV * In Range Crosstabulation
Count
Range (70-180 mg/dL)
In Range
IV

Out Range

Total

Control Group

15

11

26

Test Group

11

16

27

26

27

53

Total

Chi-Square Tests
Asymptotic

Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio

df

Significance (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

1.523a

1

.217

.920

1

.337

1.530

1

.216

Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases

.276
1.494

1

.222

53

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 12.75.
b. Computed only for a 2x2 table

.169
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Table 7: Glycemic Control
Group Statistics
IV
Pre-meal CBG

Post-meal CBG

N

Mean

Std. Deviation

Std. Error Mean

Control Group

29

168.2069

71.78111

13.32942

Test Group

30

173.8667

81.34504

14.85151

Control Group

26

171.7308

74.66863

14.64372

Test Group

27

177.2593

90.66362

17.44822

Levene's Test for Equality of Variances

F
Pre- meal

Equal variances assumed

CBG

Equal variances not assumed

Post-meal

Equal variances assumed

CBG

Equal variances not assumed

Sig.
.567

.645

t
.454

.426

df

Sig. (2-tailed)

-.283

57

.778

-.284

56.540

.778

-.242

51

.810

-.243

49.820

.809
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Table 8: Hemoglobin A1C Subgroup
Group Statistics
IV
A1C≤7 + Post-meal CBG

A1C>7 + Post-meal CBG

N

Mean

Std. Deviation

Std. Error Mean

Control Group

7

151.1429

55.86719

21.11581

Test Group

6

147.5000

77.64728

31.69937

Control Group

18

179.6111

83.26721

19.62627

Test Group

20

190.7000

93.61123

20.93211

Levene's Test for Equality
of Variances
Sig. (2F
A1C≤7 + Post-meal CBG

Equal variances assumed

Sig.
1.295

t
.279

Equal variances not

df

tailed)

.098

11

.924

.096

8.953

.926

-.384

36

.703

-.386

35.997

.701

assumed
A1C>7 + Post-meal CBG

Equal variances assumed

Equal variances not
assumed

.002

.962
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Table 9: Diet Subgroup
Group Statistics
IV
Diabetic + Post-meal CBG

Non-Diabetic + Post-meal CBG

N

Mean

Std. Deviation

Std. Error Mean

Control Group

19

181.8947

83.23654

19.09577

Test Group

25

180.6400

92.47787

18.49557

Control Group

7

144.1429

35.08290

13.26009

Test Group

2

135.0000

67.88225

48.00000

Levene's Test for Equality
of Variances
Sig. (2F
Diabetic + Post-meal CBG

Equal variances

Sig.
.070

.793

t

df

tailed)

.047

42

.963

.047

40.730

.963

.275

7

.791

.184

1.157

.881

assumed
Equal variances not
assumed
Non-Diabetic + Post-meal CBG

Equal variances

1.949

.205

assumed
Equal variances not
assumed
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Table 10: Meal Observed Subgroup
Group Statistics
IV
Breakfast + Post-meal CBG

Lunch + Post-meal CBG

N

Mean

Std. Deviation

Std. Error Mean

Control Group

5

199.4000

92.84826

41.52301

Test Group

4

128.0000

61.43289

30.71645

Control Group

21

165.1429

70.76813

15.44287

Test Group

23

185.8261

93.17659

19.42866

Levene's Test for Equality
of Variances
Sig. (2F
Breakfast + Post-meal CBG

Equal variances

Sig.
.850

t

.387

df

tailed)

1.316

7

.230

1.382

6.843

.210

-.823

42

.415

-.833

40.707

.409

assumed
Equal variances not
assumed
Lunch + Post-meal CBG

Equal variances

1.192

.281

assumed
Equal variances not
assumed

Group Statistics
IV

N

Mean

Std. Deviation

Std. Error Mean

Breakfast +Time between CBG

Control Group

5

98:00

68:17

30:32

and Tray Delivery

Test Group

5

55:24

42:09

18:51

Lunch + Time between CBG and

Control Group

24

22:07

26:48

05:28

Tray Delivery

Test Group

24

46:37

74:39

15:14

Breakfast + Time between Tray

Control Group

4

26:30

21:47

10:53

Delivery and Insulin

Test Group

4

19:30

15:09

07:34

Lunch + Time between Tray

Control Group

18

27:16

22:28

05:17

Delivery and Insulin

Test Group

21

34:37

49:29

10:47

Breakfast + Time between CBG

Control Group

4

*****

56:52

28:26

and Insulin

Test Group

3

73:20

65:29

37:48

Lunch + Time between CBG +

Control Group

18

32:03

30:32

07:11

Insulin

Test Group

21

64:25

80:28

17:33
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Levene's Test for
Equality of Variances
Sig. (2F
Breakfast +Time between CBG and

Equal variances

Tray Delivery

assumed

Sig.

1.142

.316

Equal variances not

t

df

tailed)

1.187

8

.269

1.187

6.662

.276

-1.513

46

.137

-1.513

28.832

.141

.527

6

.617

.527

5.351

.619

-.579

37

.566

-.610

28.820

.546

.626

5

.559

.611

4.041

.574

-1.608

37

.116

-1.706

26.410

.100

assumed
Lunch + Time between CBG and Tray

Equal variances

Delivery

assumed

7.546

.009

Equal variances not
assumed
Breakfast + Time between Tray

Equal variances

Delivery and Insulin

assumed

.283

.614

Equal variances not
assumed
Lunch + Time between Tray Delivery

Equal variances

and Insulin

assumed

3.858

.057

Equal variances not
assumed
Breakfast + Time between CBG and

Equal variances

Insulin

assumed

.093

.773

Equal variances not
assumed
Lunch + Time between CBG + Insulin

Equal variances

8.064

.007

assumed
Equal variances not
assumed

